Valuation: BioHarvest Sciences Inc.

Market Cap 40.8M 35.33M 33.35M 30.22M 56.71M 3.9B 57.16M 398M 153M 1.98B 153M 150M 6.3B P/E 2026 *
-3.41x
P/E 2027 * -5.37x
Enterprise Value 40.8M 35.33M 33.35M 30.22M 56.71M 3.9B 57.16M 398M 153M 1.98B 153M 150M 6.3B EV / Sales 2026 *
1.09x
EV / Sales 2027 * 0.82x
Free-Float
85.23%
Yield 2026 *
-
Yield 2027 * -
1 day-2.70%
1 week-1.10%
Current month-5.76%
1 month-13.04%
3 months-43.75%
6 months-56.63%
Current year-65.32%
1 week 1.8
Extreme 1.8
2.05
1 month 1.8
Extreme 1.8
2.63
Current year 1.8
Extreme 1.8
6.15
1 year 1.8
Extreme 1.8
12.8
3 years 0
Extreme 0.0011
12.8
5 years 0
Extreme 0.0011
17.5
10 years 0
Extreme 0.0011
67.9
Manager TitleAgeSince
Chief Executive Officer 68 29/04/2026
Director of Finance/CFO - 28/10/2024
Chief Operating Officer 65 19/04/2023
Director TitleAgeSince
Chairman 68 27/09/2018
Director/Board Member 67 27/09/2018
Director/Board Member 84 07/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
16/3/26 Option 35,049 0.1547%
16/3/26 Other

Chief Operating Officer

0 0%
16/3/26 Option

Chief Executive Officer

43,841 0.1935%
Change 5-day change 1-year change 3-year change Capi.($)
-2.70%-1.10%-79.57%-60.44% 41.94M
+0.71%-0.51%-13.95%-4.41% 13.4B
+0.73%-2.36%-33.00%-56.70% 4.78B
+1.37%-4.28%-4.54%-4.70% 4.36B
+1.25%-3.09%-10.58%-30.50% 3.78B
+0.29%-3.70%-25.45%+1.79% 3.43B
+2.46%-1.28%-1.97%-2.04% 3.41B
-0.07%-4.89%-13.78%+4.32% 3.12B
+1.11%-1.55%-23.77%-16.93% 2.27B
+0.05%-2.76%-29.76%-19.88% 1.63B
Average +0.52%-1.98%-23.64%-18.95% 4.02B
Weighted average by Cap. +0.88%-1.77%-16.10%-13.10%

Financials

2026 *2027 *
Net sales 37.42M 32.4M 30.58M 27.72M 52.01M 3.57B 52.42M 365M 140M 1.82B 141M 137M 5.78B 49.59M 42.94M 40.53M 36.73M 68.93M 4.74B 69.48M 484M 186M 2.41B 186M 182M 7.66B
Net income -12.02M -10.41M -9.82M -8.9M -16.71M -1.15B -16.84M -117M -45.12M -584M -45.14M -44.14M -1.86B -7.65M -6.62M -6.25M -5.67M -10.63M -731M -10.71M -74.58M -28.71M -372M -28.72M -28.09M -1.18B
Net Debt - -
Logo BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a Canada-based botanical synthesis company. The Company leverages its technology platform to grow plant-based compounds, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop science-based therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking plant-based compounds, and as a creator of nutraceutical health and wellness products, which include dietary supplements. It delivers phytochemicals such as age-defying antioxidants and polyphenols used for wellness. Its product pipeline is focused on polyphenols, which include grape cells, olive cells, and pomegranate cells. Its process involves selecting the specific plant cells that can create the targeted ingredients. It offers VINIA, which is a nutraceutical containing the entire matrix of polyphenols contained in red grapes, including Piceid resveratrol.
Employees
89
Date Price Change Volume
14/09/26 USD 1.800 -2.70% 13,055
11/09/26 USD 1.850 -1.07% 28,347
10/09/26 USD 1.870 +3.89% 13,761
09/09/26 USD 1.800 -0.55% 36,810
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.800USD
Average target price
10.50USD
Spread / Average Target
+483.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BHST Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!